PROVEXIS PLC Logo

PROVEXIS PLC

Develops & licenses Fruitflow®, a patented ingredient for heart health in food & supplements.

PXS | IL

Overview

Corporate Details

ISIN(s):
GB00B0923P27
LEI:
21380042E3Y3N9VZ6N48
Country:
United Kingdom
Address:
2 BLAGRAVE STREET, RG1 1AZ READING
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Provexis PLC is a life sciences company specializing in the development, licensing, and sale of scientifically-proven technologies for the functional food, medical food, and dietary supplement sectors. The company's core asset is Fruitflow®, a proprietary and patented natural ingredient clinically proven to support cardiovascular health. Provexis operates a dual business model, licensing Fruitflow® to international food and supplement companies for use in their products, while also marketing its own branded dietary supplements containing Fruitflow® and Omega-3 directly to consumers and through retail partners.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-30 09:40
Report Publication Announcement
Delay in publication of annual accounts
English 18.0 KB
2025-01-07 14:14
Related Party Transaction
Grant of Options and Warrants
English 32.6 KB
2024-12-31 14:00
Declaration of Voting Results & Voting Rights Announcements
Total Voting Rights
English 13.8 KB
2024-12-31 10:59
Interim Report
Half-year Report
English 212.7 KB
2024-12-18 08:00
Major Shareholding Notification
Purchase of Fruitflow® II SD & royalty payment
English 18.8 KB
2024-10-25 16:47
Declaration of Voting Results & Voting Rights Announcements
Result of AGM
English 24.2 KB
2024-09-30 08:00
Earnings Release
Final Results
English 384.9 KB
2024-04-30 18:00
Declaration of Voting Results & Voting Rights Announcements
Total Voting Rights
English 13.7 KB
2024-03-28 08:00
Share Issue/Capital Change
Issue of Equity - purchase of Fruitflow® II SD
English 18.8 KB
2023-12-29 13:48
Earnings Release
Half-year Report
English 198.4 KB
2023-10-26 14:51
Declaration of Voting Results & Voting Rights Announcements
Result of AGM
English 23.8 KB
2023-09-29 08:00
Earnings Release
Final Results
English 374.8 KB
2023-08-30 08:04
Regulatory News Service
BYHEALTH regulatory filing with Chinese SAMR
English 16.5 KB
2023-04-03 08:00
Capital/Financing Update
Capital structure and funding update
English 22.3 KB
2023-01-24 12:03
Remuneration Information
Grant of Share Options
English 34.0 KB

Automate Your Workflow. Get a real-time feed of all PROVEXIS PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for PROVEXIS PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
ABIVAX Logo
Developing oral drugs for chronic inflammatory diseases like ulcerative colitis and Crohn's disease.
France ABVX
Achiko AG Logo
A liquidated health tech firm that developed aptamer diagnostics and a COVID-19 passport app.
Switzerland ACHI
Addex Therapeutics Ltd Logo
Develops oral small molecule drugs, allosteric modulators, for neurological disorders.
Switzerland ADXN
Aladdin Healthcare Technologies SE Logo
Develops AI for drug discovery and diagnostics targeting age-related diseases.
Germany NMI
Alten Logo
Global engineering and IT consulting for digital transformation in industry and telecom sectors.
France ATE
Amoéba Logo
Develops amoeba-based natural fungicides for agriculture and active ingredients for cosmetics.
France ALMIB
APTAMER GROUP PLC Logo
Develops custom aptamer-based binders as antibody alternatives for life science applications.
United Kingdom APTA
Aran Research & Development (1982) Ltd. Logo
End-to-end product & machine development for plastics, medical, and industrial markets.
Israel ARAN
ARIX BIOSCIENCE PLC Logo United Kingdom ARIX
Asarina Pharma AB Logo
Developed Sepranolone for neurological disorders like Tourette's, OCD, and menstrual migraine.
Sweden ASAP

Talk to a Data Expert

Have a question? We'll get back to you promptly.